Other psychoactive substance dependence with psychoactive substance-induced sleep disorder
ICD-10 F19.282 is a billable code used to indicate a diagnosis of other psychoactive substance dependence with psychoactive substance-induced sleep disorder.
F19.282 refers to a condition characterized by dependence on psychoactive substances not classified elsewhere, accompanied by a sleep disorder induced by the substance. This diagnosis encompasses a range of substances, including but not limited to hallucinogens, inhalants, and other non-specific psychoactive agents. Patients may experience withdrawal symptoms, cravings, and significant impairment in social, occupational, or other important areas of functioning. The psychoactive substance-induced sleep disorder can manifest as insomnia, hypersomnia, or other sleep disturbances directly linked to substance use. Accurate diagnosis requires a thorough assessment of the patient's substance use history, sleep patterns, and the impact of these factors on their daily life. Treatment typically involves a combination of behavioral therapies, counseling, and, in some cases, pharmacotherapy to manage withdrawal symptoms and address sleep issues. Clinicians must be vigilant in monitoring for co-occurring mental health disorders, as these can complicate the treatment and recovery process.
Detailed patient history, including substance use and sleep patterns.
Patients presenting with insomnia linked to substance use, withdrawal symptoms, or cravings.
Consideration of co-occurring mental health disorders and their impact on treatment.
Sleep studies and assessments to differentiate between primary sleep disorders and those induced by substances.
Patients with sleep apnea or insomnia who have a history of substance use.
Need for collaboration with addiction specialists for comprehensive care.
Used when counseling patients with substance dependence.
Document the patient's substance use history and counseling provided.
Important for addiction specialists and primary care providers.
F19.282 includes a specific sleep disorder induced by the psychoactive substance, while F19.20 refers to uncomplicated dependence without such a disorder.
